Monoamine oxidase inhibition by novel antidepressant tetrindole

Abstract

The novel antidepressant tetrindole (2,3,3 a,4,5,6-hexahydro-8-cyclohexyl-1 H[3,2,1- j, k] carbazole) was found to be a selective inhibitor of monoamine oxidase A (MAO A). In vitro it inhibited rat brain mitochondrial MAO A in a competitive manner with K i value of 0.4 μM. A 60 min preincubation did not change the competitive mode of interaction between enzyme and tetrindole ( K i, value was 0.27 μM). The inhibition of rat brain mitochondrial MAO B was of mixed type with K i, value of 110 μM. Dilution or dialysis of mitochondrial suspension did not restore MAO A activity after inhibition by tetrindole both in vitro and in vivo, whereas inhibition of MAO B in vitro was completely reversible. Oral administration of tetrindole inhibited rat brain and liver mitochondrial MAO A by 80% within 0.5–1 hr and the onset of recovery of enzyme activity became evident after 24 hr. A small inhibition of MAO B (−20–30%) was observed in isolated brain and liver mitochondria within 1–6 hr and enzyme activity had completely recovered after 16 hr. The data obtained indicate that antidepressant activity of tetrindole may be explained by selective inhibition of MAO A, however an apparent discrepancy between competitive manner of MAO A inhibition in vitro and poor recovery of enzyme activity in vivo does not allow us to decide whether tetrindole is a “tight-binding” reversible inhibitor or a selective irreversible inhibitor of MAO A.